Evidence map›Paper›PMID 24565885›Full record

ReviewThe Journal of emergency medicine2014

Synthetic cathinones ("bath salts").

Matthew L Banks, Travis J Worst, Daniel E Rusyniak, Jon E Sprague

Abstract readReview
In one paragraph

Review in The Journal of emergency medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Observational
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. An updated review on synthetic cathinones.Archives of toxicology · 2021
    Review
  12. Article
  13. Molecularly imprinted polymers in toxicology: a literature survey for the last 5 years.Environmental science and pollution research international · 2021
    Review
  14. Article
  15. Review
  16. Article
  17. Flakka: New Dangerous Synthetic Cathinone on the Drug Scene.International journal of molecular sciences · 2020
    Review
  18. Article
  19. Psychoactive Bath Salts and Neurotoxicity Risk.Turkish journal of pharmaceutical sciences · 2020
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Matthew L BanksDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia.
Travis J WorstOhio Attorney General's Bureau of Criminal Investigation, London, Ohio.
Daniel E RusyniakDepartments of Emergency Medicine and Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana.
Jon E SpragueDepartment of Pharmaceutical Sciences, College of Pharmacy, Ferris State University, Big Rapids, Michigan.

Funding

Synthetic cathinones: a new class of illicit drugs affecting DAT & SERTR01DA033930 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI ELTIT, JOSE MIGUEL, GLENNON, RICHARD A · 2012 to 2016
$2.7M
NIDA NIH HHS R01 DA033930
6 · The paper itself

Abstract

backgroundSynthetic cathinones are popularly referred to in the media as "bath salts." Through the direct and indirect activation of the sympathetic nervous system, smoking, snorting, or injecting synthetic cathinones can result in tachycardia, hypertension, hyperthermia, myocardial infarction, and death.

objectiveThe chemical structures and names of bath salts identified by the Ohio Attorney General's Bureau of Criminal Investigation are presented. Based on their common pharmacophores, we review the history, pharmacology, toxicology, detection methods, and clinical implications of synthetic cathinones. Through the integration of this information, the pharmacological basis for the management of patients using synthetic cathinones is presented. DISCUSSION: Synthetic cathinones activate central serotonergic and dopaminergic systems contributing to acute psychosis and the peripheral activation of the sympathetic nervous system. The overstimulation of the sympathetic nervous system contributes to the many toxicities reported with bath salt use. The pharmacological basis for managing these patients is targeted at attenuating the activation of these systems.

conclusionsTreatment of patients presenting after using bath salts should be focused on reducing agitation and psychosis and supporting renal perfusion. The majority of successfully treated synthetic cathinones cases have used benzodiazepines and antipsychotics along with general supportive care.

Indexed as

Substance-Related DisordersAlkaloidsCentral Nervous System StimulantsDesigner DrugsHumansPsychotropic DrugsAlkaloidscathinoneCentral Nervous System StimulantsDesigner DrugsPsychotropic Drugsamphetaminebath saltsphenethylaminesympathomimeticsynthetic cathinones

Identifiers

PMID24565885
PMCPMC5556313

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.